These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27182746)

  • 1. Specialty Practice and Cost Considerations in the Management of Uveitis Associated With Juvenile Idiopathic Arthritis.
    Palestine AG; Singh JK; Kolfenbach JR; Ozzello DJ
    J Pediatr Ophthalmol Strabismus; 2016 Jul; 53(4):246-51. PubMed ID: 27182746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting therapeutic decisions in intermediate and posterior uveitis.
    Ozzello DJ; Palestine AG
    Am J Ophthalmol; 2015 Feb; 159(2):213-20.e3. PubMed ID: 25449000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatologists and Ophthalmologists Differ in Treatment Decisions for Ocular Behçet Disease.
    Palestine AG; Kolfenbach JR; Ozzello DJ
    J Clin Rheumatol; 2016 Sep; 22(6):316-9. PubMed ID: 27556239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
    Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):703-716. PubMed ID: 31021540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
    Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
    Arthritis Rheumatol; 2019 Jun; 71(6):864-877. PubMed ID: 31021511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexate.
    Kotaniemi K
    Clin Exp Rheumatol; 1998; 16(4):469-71. PubMed ID: 9706430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in juvenile idiopathic arthritis-associated uveitis.
    Zierhut M; Heiligenhaus A; deBoer J; Cunningham ET; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2013 Jun; 21(3):167-79. PubMed ID: 23713826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
    Hinze CH; Holzinger D; Lainka E; Haas JP; Speth F; Kallinich T; Rieber N; Hufnagel M; Jansson AF; Hedrich C; Winowski H; Berger T; Foeldvari I; Ganser G; Hospach A; Huppertz HI; Mönkemöller K; Neudorf U; Weißbarth-Riedel E; Wittkowski H; Horneff G; Foell D;
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):7. PubMed ID: 29357887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile idiopathic arthritis-associated uveitis.
    Sen ES; Ramanan AV
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):517-534. PubMed ID: 29773271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Henderson LA; Zurakowski D; Angeles-Han ST; Lasky A; Rabinovich CE; Lo MS;
    Pediatr Rheumatol Online J; 2016 Feb; 14(1):9. PubMed ID: 26879972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases.
    Dipasquale V; Atteritano M; Fresta J; Castagna I; Conti G
    J Clin Pharm Ther; 2019 Jun; 44(3):482-485. PubMed ID: 30815892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates.
    Khawaja K; Al-Maini M
    Pediatr Rheumatol Online J; 2017 May; 15(1):41. PubMed ID: 28511684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
    Chan AY; Liu DT
    J Rheumatol; 2006 Jan; 33(1):198; author reply 198. PubMed ID: 16395772
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis: Brazilian Evidence-based Practice Guidelines.
    Neves LM; Haefeli LM; Hopker LM; Ejzenbaum F; Moraes do Nascimento H; Aikawa N; Hilario MO; Magalhães CS; Terreri MT; Sztajnbok F; Silva C; Rossetto JD
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1384-1398. PubMed ID: 33826468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
    Bou R; Adán A; Borrás F; Bravo B; Calvo I; De Inocencio J; Díaz J; Escudero J; Fonollosa A; de Vicuña CG; Hernández V; Merino R; Peralta J; Rúa MJ; Tejada P; Antón J
    Rheumatol Int; 2015 May; 35(5):777-85. PubMed ID: 25656443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
    Constantin T; Foeldvari I; Anton J; de Boer J; Czitrom-Guillaume S; Edelsten C; Gepstein R; Heiligenhaus A; Pilkington CA; Simonini G; Uziel Y; Vastert SJ; Wulffraat NM; Haasnoot AM; Walscheid K; Pálinkás A; Pattani R; Györgyi Z; Kozma R; Boom V; Ponyi A; Ravelli A; Ramanan AV
    Ann Rheum Dis; 2018 Aug; 77(8):1107-1117. PubMed ID: 29592918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.
    Amin RM; Miserocchi E; Thorne JE; Hornbeak D; Jabs DA; Zierhut M
    Ocul Immunol Inflamm; 2016; 24(1):81-90. PubMed ID: 26652068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing juvenile idiopathic arthritis-associated uveitis.
    Hawkins MJ; Dick AD; Lee RJ; Ramanan AV; Carreño E; Guly CM; Ross AH
    Surv Ophthalmol; 2016; 61(2):197-210. PubMed ID: 26599495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.